Pre-mir-27a rs895819 polymorphism and cancer risk: A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 4, 2013, Pages 3181-3186

  Zhong, Shanliang ^a   Chen, Zhiyuan ^b,c   Xu, Jinjin ^a   Li, Wenjing ^d   Zhao, Jianhua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

^d SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Cancer; Meta analysis; miRNAs; Polymorphism; Pre mir 27a rs895819; Pre miRNA; Susceptibility

Indexed keywords

MICRORNA; PRECURSOR MICRORNA 27A; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; DNA SEQUENCE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HIGH RISK POPULATION; HUMAN; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84878423591     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2392-3     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
2. Lichtenstein P et al (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85
3. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522-531
4. Anglicheau D, Muthukumar T, Suthanthiran M (2010) MicroRNAs: small RNAs with big effects. Transplantation 90:105-112
5. Kutanzi KR et al (2011) MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics 2:171-185
6. Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259-269
7. Yang R et al (2009) A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat 121:693-702
8. Sun Q et al (2010) Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 101:2241-2247
9. Catucci I et al (2012) The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat 133:805-807
10. Hezova R et al (2012) Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol 18:2827-2831
11. Zhang M et al (2012) Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care (Engl) 21:274-280
12. Zhou Y et al (2012) Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol 138:939-945
13. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
14. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
15. Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
16. Yang R, Burwinkel B (2012) A bias in genotyping the miR-27a rs895819 and rs11671784 variants. Breast Cancer Res Treat 134:899-901
17. Mertens-Talcott SU et al (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67:11001-11011
18. Li X et al (2010) MicroRNA-27a indirectly regulates estrogen receptor alpha expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology 151:2462-2473
19. Chintharlapalli S et al (2011) Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 11:371
20. Guttilla IK, White BA (2009) Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284:23204-23216
21. Zhou L et al (2012) Mechanism and function of decreased FOXO1 in renal cell carcinoma. J Surg Oncol 105:841-847
22. Ma Y et al (2010) miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett 298:150-158
23. Lerner M et al (2011) MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle 10:2172-2183
24. Spruck C (2011) miR-27a regulation of SCF(Fbw7) in cell division control and cancer. Cell Cycle 10:3232-3233
25. Wang Q et al (2011) Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene 30:3875-3886
26. Fletcher CE et al (2012) Androgen-regulated processing of the oncomir MiR-27a, which targets prohibitin in prostate cancer. Hum Mol Genet 21:3112-3127
27. Liu T et al (2009) MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273:233-242
28. Jazdzewski K et al (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105:7269-7274
29. Duan R, Pak C, Jin P (2007) Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16:1124-1131